| EPB084 | Symptoms of depression and anxiety in adolescents and young adults living with HIV in Botswana | E-poster | Mental health (including depression and psychiatric manifestations) and HIV |
| OAB0103 | Impact of gender identity- and HIV-related stigmas and psychosocial resources on mental health and alcohol use among transgender women newly diagnosed with HIV in India: a longitudinal cohort study | Oral abstract session with live Q&A | Mental health (including depression and psychiatric manifestations) and HIV |
| OAB0104 | Forty-eight week outcomes of a combined cognitive behavioral therapy and medication management algorithm for treatment of depression among youth living with HIV in the United States (IMPAACT 2002) | Oral abstract session with live Q&A | Mental health (including depression and psychiatric manifestations) and HIV |
| PESUB16 | The burden of and risk factors for maternal mental health and the impact on parenting by mothers living with HIV in rural Zimbabwe | Poster exhibition | Mental health (including depression and psychiatric manifestations) and HIV |
| EPB223 | Childhood adversity and depression in Ugandan adolescents with perinatally-acquired HIV: differences by HIV status and adversity exposure | E-poster | Mental health and neurocognition in paediatric and adolescent populations |
| PEMOB31 | The cognitive development of children born to adolescent mothers ' does child HIV status matter? | Poster exhibition | Mental health and neurocognition in paediatric and adolescent populations |
| EPB107 | Genome-wide association study of plasma cholesterol and triglycerides among people living with HIV | E-poster | Metabolic, lipid and endocrine complications (including lipodystrophy) |
| EPB108 | Incidence of cardiometabolic outcomes among people living with HIV initiated on INSTI versus non-INSTI antiretroviral therapies | E-poster | Metabolic, lipid and endocrine complications (including lipodystrophy) |
| EPB109 | Lipid parameters and lipid modifying agent use in participants initiating F/TAF or F/TDF for PrEP in the DISCOVER trial | E-poster | Metabolic, lipid and endocrine complications (including lipodystrophy) |
| EPLBF02 | The Venezuelan migration phenomenon and the response to HIV and TB in Colombia, Ecuador and Peru | E-poster | Migration |